My Companies
Notification
Account
Log Out
Back

Beta Drugs Enters $8.7 Million Algeria Oncology JV With IMGSA Groupe


19 November 2026
Beta Drugs Ltd.

Board approved JVA with Algeria's IMGSA to form IMGSA Oncologie SPA for oncology mfg and marketing. Beta 49% for USD 3 Mn in 3 yrs plus USD 1.26 Mn tech transfer; JV to buy plant for USD 8.7 Mn. First overseas manufacturing footprint, advancing capital-light ex-India localisation strategy; cements four-year supply tie into long-term partnership with operational control despite 49% cap. JV takes over operating plant serving Algeria national tenders, fitting tender-led export push; Beta controls board and CEO. Closing, timelines and revenue share not disclosed.


Recent Events

No recent events

No events have occurred recently

Real time WhatsApp alerts using AI.

Get features of

  • Instant Notifications
  • Competitive Advantage
  • Critical Alerts
Signup or Sign in

Company Information